secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2026-07-29T10:25:46+00:00
Accession:  0001932393-26-000045
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q2 revenue up 5.7% to $5.3B; EPS $1.24; reaffirms FY guidance
---------------------------------------------------------------------------

- Revenue $5.3B (+5.7% YoY); organic revenue +3.5%; net income $561M vs $486M.
- Diluted EPS $1.24 (+16.5%); adjusted EPS $1.13 (+6.6%).
- Record organic orders growth 11.1%, book-to-bill 1.15x, backlog $23.9B.
- Patient Care Solutions revenue -13.3%, EBIT -$26M; CEO reviewing strategic options.
- Reaffirms FY2026 guidance: organic rev growth 3-4%, adj EPS $4.80-$5.00, FCF ~$1.6B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239326000045/0001932393-26-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239326000045/gehc-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001932393-26-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer